LHX2 Enhances the Malignant Phenotype of Esophageal Squamous Cell Carcinoma by Upregulating the Expression of SERPINE2

Genes (Basel). 2022 Aug 16;13(8):1457. doi: 10.3390/genes13081457.

Abstract

LHX2 dysregulations have been found to present in cancers, but the function of LHX2 in esophageal squamous cell carcinoma (ESCC) remains unknown. Here, we report that LHX2 was upregulated in ESCC tissues in comparison to the LHX2 levels in adjacent normal tissues. Loss- and gain-of-function experiments demonstrated that the knockdown of LHX2 markedly inhibited ESCC cells' proliferation, migration, invasion, tumor growth and metastasis, whereas the overexpression of LHX2 had the opposite effects. A mechanistic investigation revealed that LHX2 bound to the promoter of SERPINE2 gene and transcriptionally regulated the expression of SERPINE2. Collectively, LHX2 facilitates ESCC tumor progression, and it could be a potential therapeutic target for ESCC.

Keywords: ESCC; LHX2; SERPINE2; oncogene; tumor progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Esophageal Neoplasms* / genetics
  • Esophageal Neoplasms* / pathology
  • Esophageal Squamous Cell Carcinoma* / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • LIM-Homeodomain Proteins / genetics
  • LIM-Homeodomain Proteins / metabolism
  • Neoplasm Invasiveness / genetics
  • Phenotype
  • Serpin E2 / genetics
  • Serpin E2 / metabolism
  • Transcription Factors / genetics

Substances

  • LHX2 protein, human
  • LIM-Homeodomain Proteins
  • SERPINE2 protein, human
  • Serpin E2
  • Transcription Factors

Grants and funding

This work was supported by National Natural Science Foundation of China (82030089, 82002976, 81872227), CAMS Innovation Fund for Medical Sciences (2021-I2M-1-018, 2021-I2M-1-067), Shenzhen Key Medical Discipline Construction Fund (No. SZXK013), Sanming Project of Medicine in Shenzhen (No. SZSM201812062) and Non-Profit Central Research Institute Fund of CAMS (2018RC310009).